GreenLight Biosciences Overview

GreenLight Biosciences Research & Development

Research & Development expenses for GRNA.

Quarterly R&D Expenses

$23.17M

↑ 189.17% YoY

As of Mar 31, 2023

Annual R&D Expenses (TTM)

$129.70M

↑ 146.19% YoY

Trailing 12 months ending Mar 31, 2023

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin